Is Humana Inc. (HUM) a Buy, Sell, or Hold?
Humana Inc.
NYSE:HUM
$406.76999 USD
$0.77 (0.19%)
- Volume
- 967.14K
- Average Volume
- 1.63M
- Market Capitalization
- $48.84B
- P/E Ratio
- 43.37
- Dividend Yield
- 0.87%
- Price Target
- $320.00
- Year High
- $415.00
- Year Low
- $163.11
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.38
- Current Ratio
- $1.26
Industry, Sector & symbol
| Stock Exchange | NYSE |
| CEO | James A. Rechtin |
| Industry | Medical - Healthcare Plans |
| Sector | Healthcare |
| Current Symbol | HUM |
| CUSIP | 444859102 |
| CIK | 0000049071 |
| Web | https://www.humana.com |
| Phone | 502 580 1000 |
| Currency | USD |
| Employees | 67060 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.75 |
| Payout Ratio | 0.38 |
| Current Ratio | 1.26 |
| Quick Ratio | 1.26 |
| Cash Ratio | 0.23 |
Sales & Book Value
| Annual Sales | $129.66B |
| Price / Sales | 0.36 |
| Cash Flow | 10.57 |
| Price / Cash Flow | 38.39 |
| Price / Book | 2.63 |
Price Target and Rating
| Average Stock Price Forecast | $320.00 |
| High Stock Price Forecast | $502.00 |
| Low Stock Price Forecast | $195.00 |
| Forecast Upside/Downside | 27.12% |
| Consensus Rating | Neutral |
| Rating Score(0-5) | 3 |
| Research Coverage | 44 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $9.84 |
| Trailing P/E Ratio | 43.37 |
| PEG Ratio | -1.28 |
| P/E Growth | -1.28 |
| Net Income | $1.19B |
| Net Margin | 0.82% |
| Pretax Margin | 1.01% |
| Return on Equity | 6.19% |
| Return on Assets | 2.04% |
Financials Score
| AltmanZ Score | 4.29 |
| Piotroski Score | 8.00 |
| Working Capital | 5.68B |
| Total Assets | 55.28B |
| Ebit | 2.05B |
| Market Cap | 48.74B |
| Total Liabilities | 36.63B |
Poll Results
About Humana Inc. (NYSE:HUM) Stock
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial m ... edical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?
2026-07-13 13:40:22
Humana targets a 3% Medicare Advantage margin by 2028 while pursuing 25% 2026 membership growth and rebuilding profitability despite industry headwinds.
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?
2026-07-03 13:00:00
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, July 3, 2026
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?
2026-07-03 12:49:00
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
2026-06-30 08:00:00
LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 45 years, today announced its first slate of 2026 grants, dedicating over $12.2 million to programs and research focused on emotional well-being. The funding will support 13 nonprofit organizations and five university research teams focused on combating loneliness, depression and social isolation among seniors and veterans nationwide. The 2026 national grants scale the Foundati.
2026-06-30 07:30:00
O'Reilly's extensive experience across healthcare compliance, risk management, regulatory oversight and payer operations expected to support Dario's continued expansion with health plans, employers and providers as Dario moves closer to care O'Reilly's track record of leveraging advanced data analytics and AI in supporting value-based care strongly aligned with Dario's AI transition NEW YORK, June 30, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leader in AI-enabled digital health solutions, today announced the appointment of Sean O'Reilly to its Advisory Board. The appointment reflects Dario's continued focus on strengthening its strategic guidance as the Company advances its channel partner-led growth strategy and moves closer to care across the payer, provider and employer markets.
How CenterWell Is Driving Humana's Growth Beyond Insurance
2026-06-29 11:45:17
CenterWell's rapid growth is helping HUM expand beyond insurance with integrated care, acquisitions, AI and a 2026 revenue target of at least $25B.
Swedish care provider Ambea makes recommended $304 million offer for Humana
2026-06-29 01:56:20
Swedish care provider Ambea said on Monday it had made a recommended public offer for peer Humana , valuing the company at about 2.96 billion Swedish crowns ($304.13 million).
Can Humana's Margin Recovery Drive Long-Term Earnings Growth?
2026-06-24 12:25:30
HUM is shifting from membership growth to profitability, with lower medical costs, rising CenterWell revenues, and a margin recovery plan through 2028.
Frequently Asked Questions
-
What is the current Humana Inc. (HUM) stock price?
-
Humana Inc.(NYSE:HUM) stock price is $406.76999 in the last trading session. During the trading session, HUM stock reached the peak price of $415 while $163.11 was the lowest point it dropped to. The percentage change in HUM stock occurred in the recent session was 0.19% while the dollar amount for the price change in HUM stock was $0.77.
-
HUM's industry and sector of operation?
-
The NYSE listed HUM is part of Medical - Healthcare Plans industry that operates in the broader Healthcare sector.
-
Who are the executives of HUM?
-
James A. Rechtin | President, Chief Executive Officer & Director
Japan Mehta | Chief Information Officer
Michelle O'Hara | Chief Human Resources Officer
John-Paul W. Felter | Senior Vice President, Chief Accounting Officer & Controller
Bobby Mukundan | Senior Vice President & Chief Technology Officer -
How many employees does HUM have?
-
Number of HUM employees currently stands at 67060. HUM operates from Humana Building, Louisville, KY 40202, US.
-
Link for HUM official website?
-
Official Website of HUM is: https://www.humana.com
-
How do I contact HUM?
-
HUM could be contacted at phone #502 580 1000 and can also be accessed through its website. HUM operates from Humana Building, Louisville, KY 40202, US.
-
How many shares of HUM are traded daily?
-
The average number of HUM shares traded daily for last 3 months was 1.63M.
-
What is the market cap of HUM currently?
-
The market value of HUM currently stands at $48.84B with its latest stock price at $406.76999